HOME > ARCHIVE
ARCHIVE
- Nichiiko: Branded Generic Business Boosts Sales, Profits
February 4, 2002
- Takeda Expects 2002 to Be Year of Implementation: President
February 4, 2002
- WORLD NEWS IN BRIEF
February 4, 2002
- Fukujin to Be Listed on TSE
February 4, 2002
- Elderly Patients Should Settle Accounts with Their Insurers
February 4, 2002
- Sanuki, Ohmori Yakuhin Shikoku, Baikado to Form Koyo on April 1
February 4, 2002
- Daiwa, Kowa to Tie Up in Shikoku
February 4, 2002
- Medical Fee Reduction to Seriously Hit Medical Institutions: JMARI
February 4, 2002
- Vital-Net, Ohmori Yakuhin Tohoku Postpone Merger
February 4, 2002
- BULLETIN
February 4, 2002
- Telmisartan to Be Copromoted by NBI, Yamanouchi
February 4, 2002
- Korosho's Preparations for NHI Price Revision Delay
February 4, 2002
- WEBSITE NEWS
February 4, 2002
- Ordinary Session of Diet to Deal with Budgets
February 4, 2002
- BUSINESS NEWS IN BRIEF
February 4, 2002
- New Chugai to Achieve \300 Bil. in FY2005: Mr Ogawa of Nippon Roche
February 4, 2002
- OTC NEWS IN BRIEF
February 4, 2002
- Marketing Approval System Could Harm Local Industry: Diet Member Fujii
February 4, 2002
- Addition of 10 Medical Specialties Requested of Korosho
February 4, 2002
- Economic Incentives to Be Given to Promote Use of Generics
February 4, 2002
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
